LG

Lisa Gill

Person

Heard in 1 episode across 1 show since Jan 2026

Lisa Gill is a healthcare equity research analyst at J.P. Morgan, known for covering pharmaceutical distributors and related healthcare services companies.

Email alerts

Episodes

1
across 1 show

First heard

Jan 2026

Guest appearances

1

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20261
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20260
Sep 20260
Oct 20260

Email alert

Email me when Lisa Gill comes up on a podcast

One email a week at most, with the new episodes that mention Lisa Gill. Free, no account needed, unsubscribe in one click.

What Lisa Gill has said on podcasts

5 statements

  1. on Biotech mergers and acquisitionsPositiveJan 10, 2026· Mad Money w/ Jim Cramer

    Biotech deal activity may increase around the conference.

    “I think there's a lot of expectations around perhaps parties coming together.”

    Listen at 28:46

    Open the episode · Mad Money w/ Jim Cramer 1/9/26
  2. on Drug distributorsPositiveJan 10, 2026· Mad Money w/ Jim Cramer

    Drug distributors reduce costs for the overall healthcare system.

    “drug distributors are incredibly important and save dollars to the overall health care system”

    Listen at 29:40

    Open the episode · Mad Money w/ Jim Cramer 1/9/26
  3. on CVSPositiveJan 10, 2026· Mad Money w/ Jim Cramer

    CVS can continue delivering strong performance in 2026.

    “I really think that CBS, which is one of our favorite names going into 26, can continue to deliver.”

    Listen at 32:20

    Open the episode · Mad Money w/ Jim Cramer 1/9/26
See all 5 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

1 episode featuring Lisa Gill, newest first